IP Library Granted Patent US 10,130,457
Granted Patent B2
US 10,130,457 · App. 14/640,014 · Granted Nov 20, 2018

Surgical attachment device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,130,457
App. No.
14/640,014
Granted
Nov 20, 2018
Kind
B2
Abstract

A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.

Claims (43)

1. An implantable support device comprising:

a biologic sheet having a first longitudinal end and a second longitudinal end opposite the first longitudinal end and a first terminal edge and a second terminal edge opposite the first terminal edge, wherein the first and second terminal edges extend between the first and second longitudinal ends;

a first leader having a first leader first segment and a first leader second segment; and

multiple second leaders,

wherein at least a portion of the first leader is stitched through the biologic sheet across a reference plane that extends through the biologic sheet when the biologic sheet is in a planar configuration, wherein the at least a portion of the first leader comprises the first leader first and second segments,

wherein the at least a portion of the first leader changes direction at least once between two adjacent second leaders such that the first leader first segment extends at least partially toward the first longitudinal end through the biologic sheet across the reference plane and the first leader second segment extends at least partially away from the first longitudinal end through the biologic sheet across the reference plane between the two adjacent second leaders, and

wherein two second leaders are separated by a first gap at a longitudinal center of the biologic sheet and by a second gap at the first longitudinal end of the biologic sheet, and wherein the first gap is wider than the second gap.

2. The device of claim 1 , wherein the first leader comprises a synthetic material.

3. The device of claim 1 , wherein a length of at least one of the multiple second leaders extends through the biologic sheet.

4. The device of claim 1 , wherein a length of the first leader has a sinusoidal shape.

5. The device of claim 1 , wherein the biologic sheet comprises collagen.

6. The device of claim 1 , wherein the first leader comprises a non-biodegradable polymer.

7. The device of claim 1 , wherein the first leader comprises a monofilament.

8. The device of claim 1 , wherein the biologic sheet comprises cells, and wherein 70% or more of the cells in the biologic sheet have been removed or disrupted.

9. The device of claim 1 , wherein the biologic sheet comprises cells, and wherein 80% or more of the cells in the biologic sheet have been removed or disrupted.

10. The device of claim 1 , wherein the biologic sheet comprises a first layer and a second layer, and wherein the first layer is stitched to the second layer by the first leader.

11. The device of claim 1 , wherein when the device is in a first configuration the first leader exerts a first resistive force, wherein when the device is in a second configuration the first leader exerts a second resistive force, and wherein the first resistive force is less than the second resistive force.

12. The device of claim 1 , wherein the multiple second leaders have multiple corresponding second leader first ends and second leader second ends, and wherein the second leader first ends converge toward the first longitudinal end and the second leader second ends converge toward the second longitudinal end such that the first gap is wider than the second gap.

13. The device of claim 1 , wherein the first leader terminates at the first and second terminal edges, and wherein at least some of the second leaders terminate at the first and second longitudinal ends.

14. The device of claim 1 , wherein the first leader extends across the biologic sheet between the first and second terminal edges at least twice, and wherein at least some of the second leaders terminate at first and second longitudinal terminal ends.

15. The device of claim 1 , wherein the first longitudinal end of the biologic sheet comprises a first longitudinal end terminal end and wherein the second longitudinal end of the biologic sheet comprises a second longitudinal end terminal end.

16. A surgical attachment device comprising:

a biologic sheet having a first terminal edge and a second terminal edge opposite the first terminal edge; and

a first leader, a second leader, and a third leader,

wherein the first leader intersects the second and third leaders,

wherein at least a portion of the first leader is stitched through the biologic sheet across a reference plane that extends through the biologic sheet when the biologic sheet is in a planar configuration, wherein the reference plane is parallel with at least a portion of a top surface of the biologic sheet when the biologic sheet is in a planar configuration, and

wherein a length of the at least a portion of the first leader extends in a zig-zag configuration through the biologic sheet across the reference plane between the second and third leaders,

wherein when the device is in a first configuration the first leader exerts a first resistive force, wherein when the device is in a second configuration the first leader exerts a second resistive force, and wherein the first resistive force is less than the second resistive force, and

wherein the first leader terminates at the first and second terminal edges, wherein the second and third leaders are separated by a first gap at a longitudinal center of the biologic sheet and by a second gap at a first longitudinal end of the biologic sheet, and wherein the first gap is wider than the second gap.

17. The device of claim 16 , wherein the first, second, and third leaders comprise a synthetic material.

18. The device of claim 16 , wherein the biologic sheet comprises cells, and wherein 70% or more of the cells in the biologic sheet have been removed or disrupted.

19. The device of claim 16 , wherein the zig-zag configuration comprises at least one of a sinusoidal-shaped configuration, a V-shaped configuration, or a W-shaped configuration.

20. An implantable support device comprising:

a biologic sheet;

a first leader; and

a second leader having a second leader first segment and a second leader second segment,

wherein at least a portion of the first leader extends through the biologic sheet across a reference plane that extends through the biologic sheet when the biologic sheet is in a planar configuration, wherein the reference plane is parallel with at least a portion of a top surface of the biologic sheet when the biologic sheet is in a planar configuration,

wherein a length of the at least a portion of the first leader extends in a zig-zag configuration through the biologic sheet across the reference plane between the second leader first and second segments,

wherein when the device is in a first configuration the first leader exerts a first resistive force, wherein when the device is in a second configuration the first leader exerts a second resistive force, and wherein the first resistive force is less than the second resistive force, and

wherein the first leader terminates at first and second terminal edges of the biologic sheet, wherein the second leader terminates at a first and/or second longitudinal end of the biologic sheet, wherein the first and second segments are separated by a first gap at a longitudinal center of the biologic sheet and by a second gap at the first and/or second longitudinal end of the biologic sheet, and wherein the first gap is wider than the second gap.

21. The device of claim 20 , wherein the zig-zag configuration comprises at least one of a sinusoidal-shaped configuration, a V-shaped configuration, or a W-shaped configuration.

22. The device of claim 20 , wherein the biologic sheet comprises cells, and wherein 70% or more of the cells in the biologic sheet have been removed or disrupted.

23. The device of claim 20 , wherein the second leader changes direction at a first and/or second longitudinal end of the biologic sheet such that the second leader extends across the device from the first longitudinal end to the second longitudinal end at least twice.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Nov 14, 2025
From: MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 072912/0103 →
SECURITY INTEREST Recorded Nov 14, 2025
From: TELA BIO, INC.
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 072905/0537 →
RELEASE OF SECURITY INTEREST Recorded Aug 24, 2022
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: TELA BIO, INC.
Reel/Frame 060888/0585 →
SECURITY INTEREST Recorded Aug 24, 2022
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 060888/0633 →
RELEASE OF SECURITY INTEREST Recorded Aug 15, 2019
From: HERCULES CAPITAL, INC.
To: TELA BIO, INC.
Reel/Frame 050061/0654 →
RELEASE OF SECURITY INTEREST (TERM) Recorded Nov 16, 2018
From: MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 047587/0033 →
SECURITY INTEREST Recorded Nov 16, 2018
From: TELA BIO, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 047526/0281 →
RELEASE OF SECURITY INTEREST (REVOLVING) Recorded Nov 16, 2018
From: MIDCAP FUNDING IV TRUST, AS SUCCESSOR IN INTEREST TO MIDCAP FINANCIAL TRUST
To: TELA BIO, INC.
Reel/Frame 047586/0986 →
SECURITY INTEREST (REVOLVER) Recorded Apr 27, 2018
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046026/0680 →
SECURITY INTEREST (TERM) Recorded Apr 27, 2018
From: TELA BIO, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 046026/0749 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2018
From: ORBIMED PRIVATE INVESTMENTS IV, LP
To: TELA BIO, INC.
Reel/Frame 045630/0510 →
SECURITY INTEREST Recorded Apr 4, 2017
From: TELA BIO, INC.
To: HERCULES CAPITAL, INC.
Reel/Frame 041849/0154 →
SECURITY INTEREST Recorded Jan 25, 2017
From: TELA BIO, INC.
To: ORBIMED PRIVATE INVESTMENTS IV, LP
Reel/Frame 041082/0677 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2015
From: GREENHALGH, E. SKOTT; ROMANO, JOHN-PAUL
To: TELA BIO, INC.
Reel/Frame 036114/0997 →
Cited By (5)
US 12,208,000 US 12,226,299 US 12,318,275 US 12,419,996 US 12,508,116